Predictors of non-response to Hepatitis B vaccination in dialysis patients
Predictors of non-response to Hepatitis B vaccination in dialysis patients
Document number : 152741
Created by: Nicole Leather, 2014-06-27
Last revised by: Nicole Leather, 2015-09-03
Document created in: James Cook University

Not uppdated, final reminderNot uppdated, final reminder

1. Summary

Abstract for the general public

Due to the immunosuppression associated with uraemia, patients with end-stage renal disease have a reduced response to vaccination. The hepatitis B vaccine is routinely administered to all dialysis patients, however vaccine coverage is suboptimal. This study is aimed at determining predictors of non-seroconversion to the vaccine in this population.

Tutor

John Killen
Renal physician, Renal Unite, Cairns Private Hospital
Ronny Gunnarsson
Adjunct Professor at University of Gothenburg, Sweden, Avdelningen för samhällsmedicin och folkhälsa, Närhälsan FoU-centrum Södra Älvsborg

Workplaces involved in this project

information Added workplaces
Education - James Cook University (JCU) - Division of Tropical Health and Medicine - College of Medicine and Dentistry - Medicine - Cairns, Clinical School workplace verified by James Cook University on 2018-02-27
Health Care - Health care providers - Queensland Health - Cairns and Hinterland Hospital and Health Service - Cairns Hospital - Medicine - Renal services

3. Ethics and information for classification purposes

Waiver of the need for individual consent

A waiver of the need for individual consent is given by a HREC

Date commenced

2014-01-01

Predictors of non-response to Hepatitis B vaccination in dialysis patients, from James Cook University
http://au.researchweb.org/is/jcu/document/152741